Neogen Corp. (NEOG) Tops Q4 EPS by 12c, provides outlook

Neogen Corp. (NASDAQ: NEOG) reported Q4 EPS of $0.10, $0.12 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $236.8 million versus the consensus estimate of $224.75 million.

GUIDANCE:

Neogen Corp. sees FY2025 revenue of $925-955 million, versus the consensus of $937.5 million. Adjusted EBITDA is expected to be $215 million to $235 million, while capital expenditures are expected to be approximately $85 million, including approximately $55 million related specifically to the integration of the former 3M Food Safety Division.

For earnings history and earnings-related data on Neogen Corp. (NEOG) click here.

You May Also Be Interested In

• Barclays Starts DKSH Holding AG (DKSH:SW) at Overweight
• Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
• Barclays Reiterates Overweight Rating on Tele2 AB (TEL2B:SS) (TLTZY)